
By Liz Moyer
Investing.com -- Stocks reversed early losses and were rising on Tuesday as investors swooped in to bargain hunt. Here are the midday movers for Dec. 20.
Tesla Inc (NASDAQ:TSLA) shares fell 5.6% after Evercore ISI cut its price target, citing challenges with production in China and the continuing drama at Twitter as CEO Elon Musk is reportedly on a search for a CEO for the social media platform he bought in October.
General Mills Inc (NYSE:GIS) stock fell 4% after the cereal and packaged foods maker beat expectations for revenue and profit and raised its full-year forecast. Higher prices helped it offset rising costs.
Wells Fargo &Company (NYSE:WFC) stock fell 1% after the banking giant agreed to a $3.7 billion settlement with the Consumer Financial Protection Bureau over allegations of loan mismanagement.
Moderna Inc (NASDAQ:MRNA) stock rose 6.6% after Jefferies upgraded it to buy from hold, citing growth opportunities for the pharmaceutical company beyond the COVID-19 vaccine that made it famous. Last week it announced its experimental cancer vaccine reduced the risk of death in skin cancer patients who were also using Merck's Keytruda.
Curaleaf Holdings Inc (OTC:CURLF) stock fell 5.5% after the federal budget bill being hammered out on Capitol Hill this week failed to include a provision to allow cannabis companies access to banks. Trulieve Cannabis Corp (OTC:TCNNF) shares fell 4.8%.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.